Nikolas Ruffer Selected Research

Vasculitis (Vasculitides)

9/2023	[Cocaine-induced vasculitis and mimics of vasculitis].
11/2019	Cocaine-induced ANCA-associated renal disease: a case-based review.
1/2019	Tocilizumab treatment in refractory polyarteritis nodosa: a case report and review of the literature.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nikolas Ruffer Research Topics

Disease

3	Vasculitis (Vasculitides) 09/2023 - 01/2019
2	Antisynthetase syndrome 12/2023 - 01/2023
2	Autoimmune Diseases (Autoimmune Disease) 12/2023 - 12/2022
2	VEXAS syndrome 11/2023 - 01/2023
2	Felty Syndrome (Syndrome, Felty's) 04/2022 - 04/2022
2	Rheumatoid Arthritis 04/2022 - 04/2022
2	Visceral Leishmaniasis (Kala Azar) 04/2022 - 04/2022
2	Stress Fractures (Stress Fracture) 01/2022 - 01/2022
2	Polyarteritis Nodosa (Periarteritis Nodosa) 10/2020 - 01/2019
1	Communicable Diseases (Infectious Diseases) 01/2024
1	Systemic Vasculitis 09/2023
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 09/2023
1	Dermatomyositis (Dermatopolymyositis) 12/2022
1	Infections 12/2022
1	COVID-19 12/2022
1	Rheumatic Diseases (Rheumatism) 04/2022
1	Fever (Fevers) 04/2022
1	Pancytopenia 04/2022
1	Splenomegaly 04/2022
1	Necrosis 04/2022
1	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2022
1	Arthritis (Polyarthritis) 01/2022
1	Sarcoidosis (Schaumann Disease) 01/2022
1	Referred Pain 01/2022
1	Muscular Diseases (Myopathy) 11/2020
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 11/2019
1	Leukopenia 11/2019
1	Anemia 11/2019
1	Panniculitis 01/2019
1	Polyneuropathies (Polyneuropathy) 01/2019
1	Fasciitis (Fascitis) 01/2019
1	Tenosynovitis 01/2019

Drug/Important Bio-Agent (IBA)

4	Methotrexate (Mexate)FDA LinkGeneric 04/2022 - 01/2022
3	AutoantibodiesIBA 12/2023 - 04/2022
2	EnzymesIBA 11/2023 - 01/2023
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 09/2023 - 11/2019
2	Levamisole (Decaris)FDA Link 09/2023 - 11/2019
2	Cocaine (Cocaine HCl)IBA 09/2023 - 11/2019
2	Etanercept (Enbrel)FDA Link 04/2022 - 04/2022
2	tocilizumab (atlizumab)FDA Link 10/2020 - 01/2019
1	AntibodiesIBA 12/2023
1	daratumumabIBA 12/2023
1	Rituximab (Mabthera)FDA Link 01/2023
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2023
1	Interferon Type IIBA 12/2022
1	InterferonsIBA 12/2022
1	BNT162 VaccineIBA 12/2022
1	Viral RNAIBA 12/2022
1	CytokinesIBA 04/2022
1	Oxidoreductases (Dehydrogenase)IBA 11/2020
1	Antinuclear AntibodiesIBA 11/2019
1	Antiphospholipid AntibodiesIBA 11/2019
1	Complement System Proteins (Complement)IBA 11/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019

Therapy/Procedure

5	Therapeutics 12/2023 - 01/2019
1	Critical Care (Surgical Intensive Care) 01/2024
1	Plasma Exchange 01/2023
1	Tattooing 01/2022
1	Plasmapheresis 11/2020